Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor

被引:53
作者
Cavaletti, G
Pezzoni, G
Pisano, C
Oggioni, N
Sala, F
Zoia, C
Ferrarese, C
Marmiroli, P
Tredici, G
机构
[1] S Gerardo Hosp, Dept Neurosci, Neurol Unit, I-20052 Monza, Italy
[2] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy
[3] Nuvuspharma SpA, Dept Biol, I-20052 Monza, Italy
[4] SigmaTau SpA, R&D, Dept Oncol, I-00040 Pomezia, Italy
关键词
cisplatin; nerve growth factor; toxicity; pathology; neurophysiology; neurotrophins;
D O I
10.1016/S0304-3940(02)00091-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The pathogenesis of the neurotoxicity of most antineoplastic drugs is unknown. Recent reports suggest that changes in the circulating levels of nerve growth factor (NGF) might be related to the dorsal root ganglia sensory neuron damage induced by cisplatin (CDDP), the first member of a family of widely used and very effective platinum-derived anticancer agents. Using a well-characterized model of CDDP neurotoxicity, we demonstrated that the NGF circulating level decreased during chronic CDDP administration in close accordance with the clinical course and returned to normal levels after recovery from the neurotoxic damage. Moreover, these changes were restricted to NGF and did not involve other trophic factors of the same neurotrophin family. Our findings are in agreement with previous in vitro and in vivo results and further suggest that NGF plays a specific role in the course of CDDP-induced primary sensory neuron damage. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 20 条
[1]   Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by Cisplatin: behavioral, structural and biochemical analysis [J].
Aloe, L ;
Manni, L ;
Properzi, F ;
De Santis, S ;
Fiore, M .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2000, 86 (1-2) :84-93
[2]  
Apfel SC, 1999, BRAIN PATHOL, V9, P393
[3]   NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY [J].
APFEL, SC ;
AREZZO, JC ;
LIPSON, L ;
KESSLER, JA .
ANNALS OF NEUROLOGY, 1992, 31 (01) :76-80
[4]   Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy [J].
Apfel, SC ;
Kessler, JA ;
Adornato, BT ;
Litchy, WJ ;
Sanders, C ;
Rask, CA .
NEUROLOGY, 1998, 51 (03) :695-702
[5]   Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy [J].
Barajon, I ;
Bersani, M ;
Quartu, M ;
DelFiacco, M ;
Cavaletti, G ;
Holst, JJ ;
Tredici, G .
EXPERIMENTAL NEUROLOGY, 1996, 138 (01) :93-104
[6]  
De Santis S, 2000, CLIN CANCER RES, V6, P90
[7]   Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia [J].
Fischer, SJ ;
Podratz, JL ;
Windebank, AJ .
NEUROSCIENCE LETTERS, 2001, 308 (01) :1-4
[8]   NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: In vitro study of adult rat sympathetic ganglion explants [J].
Hayakawa, K ;
Itoh, T ;
Niwa, H ;
Mutoh, T ;
Sobue, G .
BRAIN RESEARCH, 1998, 794 (02) :313-319
[9]   REVERSAL BY NGF OF CYTOSTATIC DRUG-INDUCED REDUCTION OF NEURITE OUTGROWTH IN RAT DORSAL-ROOT GANGLIA IN-VITRO [J].
KONINGS, PNM ;
MAKKINK, WK ;
VANDELFT, AML ;
RUIGT, GSF .
BRAIN RESEARCH, 1994, 640 (1-2) :195-204
[10]   IMAGE-ANALYSIS OF NEURITIC REGENERATION BY ADULT-RAT DORSAL-ROOT GANGLION NEURONS IN CULTURE - QUANTIFICATION OF THE NEUROTOXICITY OF ANTICANCER AGENTS AND OF ITS PREVENTION BY NERVE GROWTH-FACTOR OR BASIC FIBROBLAST GROWTH-FACTOR BUT NOT BRAIN-DERIVED NEUROTROPHIC FACTOR OR NEUROTROPHIN-3 [J].
MALGRANGE, B ;
DELREE, P ;
RIGO, JM ;
BARON, H ;
MOONEN, G .
JOURNAL OF NEUROSCIENCE METHODS, 1994, 53 (01) :111-122